Clinical TrialsSearch results
Number of results: 271
Other
- Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)
- esophageal neoplasm
- Japan Clinical Oncology Group (JCOG)
- 2009-02-27
Recruiting
- Phase I clinical study on the safety of HER2-specific chimeric antigen receptor (CAR) gene-modified T cell therapy
- HER2 positive osteosarcoma/soft tissue sarcoma and gynecologic malignancy
- Yozo Nakazawa
- 2022-05-25
Other
- Phase 2 study of induction and early consolidation therapy for acute lymphoblastic leukemia in children (TCCSG ALL L04-16).
- Acute Lymphoblastic Leukemia
- Tokyo Children's Cancer Study Group
- 2008-10-05
Other
- Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Phase 2 study of cisplatin and pemetrexed in previously treated patients with malignant pleural mesothelioma
- Malignant pleural mesothelioma
- Hyogo College of Medicine
- 2008-01-04
Other
- Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients with BCR-ABL-Negative Acute Lymphoblastic Leukemia (JALSG ALL202-U)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Completed
- Pegcetacoplan Long-term Safety and Efficacy Extension Study
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Uchendu Uchendu
- 2022-04-28
Other
- PEARL Study(PITAVASTATIN HEART FAILURE Study)
- Chronic heart failure
- Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine
- 2006-06-09
Other
- Paclitaxel plus cisplatin and concurrent radiation for unresectable, locally recurrent or remnant gastric cancer in the left upper abdomen – phase I study
- unresectable, locally recurrent or remnant gastric cancer
- Multi-modality therapy for gastric cancer study group
- 2005-09-22